BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 23855290)

  • 1. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.
    Fan JG
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():11-7. PubMed ID: 23855290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of fatty liver disease and its risk factors in the population of South China.
    Zhou YJ; Li YY; Nie YQ; Ma JX; Lu LG; Shi SL; Chen MH; Hu PJ
    World J Gastroenterol; 2007 Dec; 13(47):6419-24. PubMed ID: 18081233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China.
    Li H; Wang YJ; Tan K; Zeng L; Liu L; Liu FJ; Zhou TY; Chen EQ; Tang H
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):377-82. PubMed ID: 19666406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of non-alcoholic fatty liver disease in China.
    Fan JG; Farrell GC
    J Hepatol; 2009 Jan; 50(1):204-10. PubMed ID: 19014878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of rs738409, obesity, and alcohol: a population-based autopsy study.
    Dunn W; Zeng Z; O'Neil M; Zhao J; Whitener M; Yu-Jui Wan Y; Mitchell EK; Handler M; Weinman SA
    Am J Gastroenterol; 2012 Nov; 107(11):1668-74. PubMed ID: 23032985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic effect of alcohol intake on the development of fatty liver disease.
    Takahashi H; Ono M; Hyogo H; Tsuji C; Kitajima Y; Ono N; Eguchi T; Fujimoto K; Chayama K; Saibara T; Anzai K; Eguchi Y
    J Gastroenterol; 2015 Nov; 50(11):1114-23. PubMed ID: 25733100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors of fatty liver in Portuguese adults.
    Leitão J; Carvalhana S; Cochicho J; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Oliveiros B; Rodrigues V; Sousa R; Sampaio F; Carvalho A; Cortez-Pinto H
    Eur J Clin Invest; 2020 Jun; 50(6):e13235. PubMed ID: 32289180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?
    Völzke H
    World J Gastroenterol; 2012 Jul; 18(27):3492-501. PubMed ID: 22826613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.
    Kwon YM; Oh SW; Hwang SS; Lee C; Kwon H; Chung GE
    Am J Gastroenterol; 2012 Dec; 107(12):1852-8. PubMed ID: 23032980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology, pathogenesis and histopathology of fatty liver disease.
    Levene AP; Goldin RD
    Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.
    Liu CJ
    J Gastroenterol Hepatol; 2012 Oct; 27(10):1555-60. PubMed ID: 22741595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
    Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey.
    Kotronen A; Yki-Järvinen H; Männistö S; Saarikoski L; Korpi-Hyövälti E; Oksa H; Saltevo J; Saaristo T; Sundvall J; Tuomilehto J; Peltonen M
    BMC Public Health; 2010 May; 10():237. PubMed ID: 20459722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China.
    Yan J; Xie W; Ou WN; Zhao H; Wang SY; Wang JH; Wang Q; Yang YY; Feng X; Cheng J
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1654-9. PubMed ID: 23731053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease.
    Mahli A; Hellerbrand C
    Dig Dis; 2016; 34 Suppl 1():32-9. PubMed ID: 27548267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
    Manco M
    J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study.
    Zhang T; Zhang C; Zhang Y; Tang F; Li H; Zhang Q; Lin H; Wu S; Liu Y; Xue F
    Atherosclerosis; 2015 May; 240(1):144-8. PubMed ID: 25785362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Fatty Liver Disease versus Alcohol-related Liver Disease: Is it Really so Different?
    Craciun A; Lackner C; Cortez-Pinto H
    Curr Pharm Des; 2020; 26(10):1093-1109. PubMed ID: 31969088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.